| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,038,028 |
|
|
|
Indirect Value
|
$374,282,250 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$536,320,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-06-27 |
4 |
S |
$17.34 |
$927,777 |
I/I |
(53,505) |
3,945,650 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-14 |
4 |
S |
$17.36 |
$5,262,996 |
I/I |
(303,168) |
3,096,119 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-09 |
4 |
S |
$17.48 |
$3,900,260 |
I/I |
(223,127) |
3,396,879 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-22 |
4 |
S |
$17.49 |
$13,675,099 |
I/I |
(781,881) |
2,430,247 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-08 |
4 |
S |
$17.52 |
$2,570,499 |
I/I |
(146,718) |
3,529,470 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-28 |
4 |
S |
$18.02 |
$7,789,127 |
I/I |
(432,249) |
1,897,610 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2018-04-30 |
4 |
A |
$18.18 |
$999,984 |
I/I |
51,775 |
14,788,996 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-24 |
4 |
S |
$18.20 |
$1,881,370 |
I/I |
(103,372) |
2,219,466 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-27 |
4 |
S |
$18.22 |
$1,992,849 |
I/I |
(109,377) |
2,154,470 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-23 |
4 |
S |
$18.48 |
$4,644,671 |
I/I |
(251,335) |
2,280,894 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-08-31 |
4 |
A |
$18.63 |
$999,974 |
I/I |
53,077 |
13,471,450 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-08-11 |
4 |
B |
$18.85 |
$2,499,981 |
I/I |
132,625 |
6,782,622 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-09-29 |
4 |
A |
$19.01 |
$999,966 |
I/I |
51,820 |
13,481,970 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-02-26 |
4 |
OE |
$19.45 |
$3,585,802 |
I/I |
184,360 |
193,343 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-11-17 |
4 |
A |
$19.56 |
$6,000,014 |
I/I |
306,710 |
102,236 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-04-28 |
4 |
A |
$19.67 |
$999,979 |
I/I |
50,267 |
5,335,131 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-03-31 |
4 |
A |
$19.82 |
$999,980 |
I/I |
47,897 |
5,325,535 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-05-18 |
4 |
B |
$20.00 |
$2,000,000 |
I/I |
100,000 |
366,246 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-01-31 |
4 |
A |
$21.16 |
$999,980 |
I/I |
41,748 |
5,306,661 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-05-31 |
4 |
A |
$21.32 |
$999,961 |
I/I |
40,544 |
5,344,511 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-07-31 |
4 |
A |
$21.59 |
$999,985 |
I/I |
43,850 |
13,461,314 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-07-17 |
4 |
B |
$22.00 |
$49,500,000 |
I/I |
2,250,000 |
2,250,000 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-06-30 |
4 |
A |
$22.82 |
$999,973 |
I/I |
43,358 |
5,352,813 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-02-09 |
4 |
A |
$23.40 |
$3,588,507 |
I/I |
153,355 |
153,353 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-05-13 |
4 |
B |
$23.92 |
$1,000,574 |
I/I |
41,830 |
6,649,997 |
2.64 |
- |
|
271 Records found
|
|
Page 10 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
